Predicting poor outcomes in children aged 1-12 with respiratory tract infections: A systematic review

George Edwards1, Louise Newbould2, Charlotte Nesbitt1

  • 1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

Plos One
|April 19, 2021
PubMed

Insights

Identifying respiratory tract infections (RTIs) in children requires understanding prognostic indicators. While some signs predict hospitalization, more research is needed to empower parents in recognizing poor prognosis at home.

Area of Science:

  • Pediatrics
  • Public Health
  • Clinical Medicine

Background:

  • Respiratory tract infections (RTIs) are a leading cause of primary care consultations for children.
  • High demand for healthcare services necessitates better tools for managing childhood illnesses.
  • Understanding prognostic factors in pediatric RTIs is crucial for developing effective parental support and interventions.

Purpose of the Study:

  • To identify symptoms, signs, and investigation results linked to good and poor prognoses in children aged 1-12 years with RTIs.
  • To inform clinical decision-making for children presenting with RTI symptoms in ambulatory care settings.
  • To explore prognostic indicators for children managed at home and in healthcare settings.

Main Methods:

  • A systematic literature review was conducted across major databases (MEDLINE, EMBASE, Cinahl, Web of Science, Cochrane).
  • Studies included children aged 1-12 years with RTIs, focusing on symptoms, signs, and investigations related to prognostic outcomes.
  • Study quality was assessed using the QUIPS tool, with 27 studies included, encompassing 34,802 children.

Main Results:

  • Respiratory signs, vomiting, fever, dehydration, and tachycardia at initial contact were associated with future hospitalization.
  • Limited evidence was found for prognostic indicators related to outcomes other than hospitalization.
  • None of the included studies focused on the home management setting for predicting prognosis.

Conclusions:

  • Current evidence aids clinicians in stratifying the risk of hospitalization for pediatric RTIs, but not for other prognostic outcomes.
  • There is a significant gap in evidence to help parents identify children at risk of poor prognosis.
  • Further research is recommended to investigate the potential for parents to predict poor outcomes at home.
Abstract

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
557
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
269
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
629
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
553